Loading CLB total return...
Loading summary...

About CLB Dividend Returns

Core Laboratories N.V. (CLB) is a dividend-paying stock. When dividends are reinvested through a DRIP (Dividend Reinvestment Plan), they purchase additional shares, which then generate their own dividends—creating a compounding effect that can significantly boost long-term returns.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of CLB over the past year?

Core Laboratories N.V. (CLB) delivered a total return of 5.28% over the past year when dividends are reinvested. The price-only return was 4.95%, meaning dividends contributed an additional 0.33 percentage points to total returns.

Q2How much would $10,000 invested in CLB be worth today?

A $10,000 investment in Core Laboratories N.V. one year ago would be worth $10,528 today with dividends reinvested (DRIP). Without reinvesting dividends, the same investment would be worth $10,495. Dividend reinvestment added $33 to the portfolio value.

Q3Does CLB pay dividends?

Yes, Core Laboratories N.V. (CLB) pays dividends. In the last year, CLB paid approximately $0.04 per share in dividends (0.32% yield). Reinvesting these dividends through a DRIP can significantly boost long-term returns — over 20+ years, dividend compounding can account for 30–50% of total returns for dividend-paying stocks.

Q4Did CLB beat the S&P 500?

No, Core Laboratories N.V. (CLB) underperformed the S&P 500 by 19.97 percentage points over the past year. CLB delivered a total return of 5.28%, compared to the S&P 500's 25.25%. This means a passive S&P 500 index fund outperformed CLB by 19.97pp during this period.

Q5What is CLB's worst drawdown?

Core Laboratories N.V. (CLB) experienced a maximum drawdown of -34.27% over the past year, declining from its peak on 2026-01-27 to its trough on 2026-06-15. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is CLB's long-term total return over 10, 20, or 30 years?

Here are Core Laboratories N.V. (CLB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -83.0% (-16.2% CAGR) — $10,000 would have grown to $1,700. Over 20 years: 19.8% total return (0.9% CAGR) — $10,000 → $11,979. Over 30 years: 751.7% total return (7.4% CAGR) — $10,000 → $85,171. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was CLB's best and worst year?

Core Laboratories N.V.'s best calendar year was 1997 with a total return of 115.5%. Its worst year was 2008 with a total return of -52.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 167.9 percentage points.

Find the Best Total Return Stocks

Screen for dividend stocks with the strongest long-term returns, including DRIP compounding.

View Dividend Stocks →

How much would $100/month in CLB be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →

Compare Similar Stocks

Deep Dive into CLB